6172777
Last Update Posted: 2024-09-05
Recruiting has ended
All Genders accepted | 18 Years + |
72 Estimated Participants | No Expanded Access |
Observational Study | Does not accept healthy volunteers |
A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD
The study to evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD, it is a multi-centre clinical study. sponsor by Astrazeneca Investment(China) Co.,LTD.
800 patients, including suspected or confirmed asthma, suspected or confirmed COPD, will be enrolled in nationwide multiple study centres. Enrolling suspected and confirmed subject in an approximate1:1 rate in centre-level. About 100 subjects were enrolled at the leader site, while about 14 subjects were enrolled at other sites.
To evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD.
Eligibility
Relevant conditions:
Asthma/ COPD
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
AstraZeneca Clinical Study Information Center
information.center@astrazeneca.com
1-877-240-9479
Data sourced from ClinicalTrials.gov